Related Experiment Videos
[The fellow eye in acute angle-closure glaucoma (author's transl)]
Klinische Monatsblatter Fur Augenheilkunde
|August 1, 1976
Summary
Preventive miotic therapy is insufficient for fellow eyes after acute angle-closure glaucoma. Chronic angle-closure glaucoma developed in 42% of patients, suggesting prophylactic iridectomy is necessary.
Area of Science:
- Ophthalmology
- Glaucoma Research
Context:
- Acute angle-closure glaucoma (AACG) in one eye poses a risk to the fellow eye.
- Previous studies indicate a significant risk of contralateral disease.
- The efficacy of miotic therapy in preventing fellow eye disease is under investigation.
Purpose:
- To evaluate the long-term incidence of contralateral angle-closure glaucoma (CACG) after unilateral AACG.
- To assess the effectiveness of prophylactic miotic therapy in preventing CACG.
- To determine the optimal preventive strategy for the fellow eye.
Summary:
- After 5 years, only 15% of fellow eyes developed AACG.
- However, 42% of fellow eyes developed chronic angle-closure glaucoma (CACG) despite miotic therapy.
- CACG often developed asymptomatically, highlighting a diagnostic challenge.
Impact:
- Prophylactic miotic therapy is inadequate for preventing CACG.
- Preventive iridectomy in the fellow eye is recommended to reduce the risk of unnoticed CACG.
- This finding may alter current clinical guidelines for managing unilateral AACG.